This year combines the World and Europe IUSTI congress into one and it is looking to be a very exciting and relevant event. The congress will be hosted in Trinity College Dublin, running under the theme of “The Appliance of Science” – emphasising the great practical advances that science has brought to our day-to-day clinical practice with patients, and to public health.
The programme will tackle newly emerging issues in the STI field, including:
the rise of Syphilis and other STIs
confronting Gonococcal Resistance
addressing Sexual Health and Quality Sex in STI practice
how STI practice can be improved through Programme Science
Mark your calendars for the SpeeDx Satellite Symposium and be sure to visit us at Booth #24 to talk about your Molecular Diagnostic needs.
Diagnostics Defining Therapy – how resistance guided therapy is changing STI management
Thursday June 28th, 2:30-3:45PM, Emmet Theatre
Learn about the latest in Gonorrhoea surveillance, M. genitalium macrolide resistance testing in Scotland and Barcelona and be part of an interesting panel discussion.
Symposium Chair: Jeff Klausner
Speakers: A/Prof David Whiley – The University of Queensland Centre for Clinical Research, Brisbane Australia Dr Kate Templeton – Royal Infirmary Edinburgh, UK Dr Mateu Espasa Soley – Vall d’Hebron Institut de Recerca, Barcelona, Spain
Panel discussion: A/Prof David Whiley, Dr Kate Templeton, Dr Elisa Mokany
Key Presentations at IUSTI Dublin
Presentation Title Mycoplasma genitalium and fluoroquinolone resistance Author
Jorgen Skov Jensen Presented
Date: Thursday June 28th
Atrium: Dining Hall @ 12:30 – 1:30PM
Antimicrobial Resistance Presentations
John White – Is Dual Therapy for Gonorrhea the Solution to the Threat of Antimicrobial Resistance?
Lisa Manhart – Resistance profiles and treatment outcomes among Mycoplasma genitalium (MG) infected men who have sex with men (MSM) with non-gonococcal urethritis (NGU)
Helen Fifer – The correlation between azithromycin minimum inhibitory concentration and clinical outcome for Gonorrhoea in the GTOG trial: does dual therapy treatment remain appropriate? Presented
Date: Friday June 29th
Edmund Burke Hall @ 11:15 – 12:30PM
Abstract Presentation Title
Gyrase a genotyping of Neisseria Gonorrhoeae for the rapid prediction of ciprofloxacin susceptibility: implementation, patient outcomes, and cost analysis Author
Jeffrey Klausner Presented
Date: Friday June 29th
Hall: Beckett Room 1 @ 3:00 – 4:15PM